Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

S100A2 coding sequence polymorphism: characterization and lack of association with psoriasis.

S W Stoll1, N V Chia, R P Nair

  • 1The Department of The Department of Dermatology, University of Michigan Medical School, MI, USA.

Clinical and Experimental Dermatology
|March 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pustular diseases and keratinocyte-myeloid synergy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Severity, heterogeneity and systemic inflammation in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Pioneers in dermatology and venereology: an interview with Prof. Enno Christophers.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Periodontitis and risk of psoriasis: another comorbidity.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Impact of early vs. late disease onset on treatment response to etanercept in patients with psoriasis.

The British journal of dermatology·2015
Same author

Bimodal immune activation in psoriasis.

The British journal of dermatology·2013

Researchers investigated a specific gene, S100A2, for its role in psoriasis. They found a common genetic variation in S100A2, but it did not significantly differ between psoriasis patients and healthy individuals, ruling out its direct cause.

Area of Science:

  • Genetics
  • Dermatology
  • Molecular Biology

Background:

  • Psoriasis is a chronic inflammatory skin condition with a significant genetic basis.
  • The 1q21 region, known as the epidermal differentiation complex, contains genes linked to psoriasis susceptibility.
  • S100A2, a gene within this region, is known to be overexpressed in psoriatic lesions.

Purpose of the Study:

  • To investigate the association between an identified A/G (Asn62Ser) polymorphism in the S100A2 gene and psoriasis.
  • To clarify conflicting literature reports regarding S100A2 gene sequences.

Main Methods:

  • DNA analysis of 38 normal and 40 psoriatic individuals.
  • Sequencing of S100A2 complementary DNAs (cDNAs).
  • Allele frequency determination for the S100A2 185A/G polymorphism using Fisher's exact test.

Related Experiment Videos

Main Results:

  • An A/G polymorphism (Asn62Ser) was identified at nucleotide 185 in the S100A2 coding region.
  • The 185G allele was highly prevalent (94.9%) in both normal (94.7%) and psoriatic (95.0%) cohorts.
  • No statistically significant difference in allele distribution was observed between normal and psoriatic individuals (P = 1.00).

Conclusions:

  • The identified S100A2 polymorphism does not appear to be a significant genetic risk factor for psoriasis.
  • This finding helps reconcile previous conflicting sequence data for S100A2.
  • The study suggests S100A2 is unlikely to have a direct causal role in the pathogenesis of psoriasis.